Clinical Trials Logo
  1. Home
  2. Skin Aging
  3. NCT00492479
  4. Details
NCT00492479 Clinical Trial

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Skin Aging Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT00492479
Other study ID # 5314
Secondary ID
Status Terminated
Phase Phase 4
First received June 25, 2007
Last updated December 18, 2007
Start date June 2007
Est. completion date December 2007

Study information
Verified date December 2007
Source Innovative Medical
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Recruitment information / eligibility
Status Terminated
Enrollment 0
Est. completion date December 2007
Est. primary completion date
Accepts healthy volunteers
Gender Female
Age group 35 Years to 55 Years
Eligibility Inclusion Criteria:

- Female patients 35-55 years of age with at least moderate signs of facial aging

- Written informed consent

- Likely to complete all study visits and follow study protocol

Exclusion Criteria:

- Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements

- Known hypersensitivity to any study product or their components

- Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)

- Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)

- Planned facial procedures during the study (microdermabrasion, facials, etc)

o Botox and fillers cannot be used during the trial or for 3 months prior to study entry

- Recent (within 60 days) or concurrent participation in another clinical trial

- Concomitant topical or systemic therapy that my interfere with study measurements or outcomes

- Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens

- Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study

- Wearing of cosmetics during study visits

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind

Related Conditions & MeSH terms

Intervention

Drug:
• Kinerase Pro+Therapy Line day repair, serum, night repair

• Kinerase Pro+Therapy Line Ultra rich day repair

• LubriDerm

Locations
Country Name City State
United States Steve Yoelin MD practice Santa Ana California

Sponsors (1)
Lead Sponsor Collaborator
Innovative Medical

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT04276753 - A Randomized, Double-blinded, Placebo Controlled, Monocentric Study to Evaluate the Anti-ageing and Skin Brightening Benefit of the Test Product in Healthy Female Subjects N/A
Completed NCT06125912 - A Comparative Split-Face Study of the Effects of a Retinol Alternative Cream on Improving Facial Skin Aging N/A
Completed NCT02580370 - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines Phase 3
Recruiting NCT01583478 - Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids Phase 4
Completed NCT02003833 - Poly-L-lactic Acid for Skin Quality Phase 4
Completed NCT01447342 - A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines Phase 2/Phase 3
Completed NCT00974480 - Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging N/A
Completed NCT00986570 - Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face Phase 3
Completed NCT00272610 - Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin Phase 2
Recruiting NCT03730649 - Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure Early Phase 1
Completed NCT03312543 - Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles N/A
Active, not recruiting NCT05349799 - TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines N/A
Completed NCT03677258 - Effectiveness and Safety of Collagen Complex COLLOST in Anti-age Therapy N/A
Withdrawn NCT05854628 - The Role of Red Flavonoid in Photoaging N/A
Completed NCT01981980 - Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation N/A
Not yet recruiting NCT00767156 - Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging N/A
Recruiting NCT05813054 - Clinical Study to Evaluate the Anti-aging Efficacy of Dermial® N/A
Not yet recruiting NCT04485091 - TCA Peel and Photobiomodulation for Hand Rejuvenation Phase 2
Completed NCT05457491 - Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE) Phase 1
Completed NCT01237977 - Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines Phase 3